Brief: Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration
02/07/2026 02:33
BRIEF-Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration July 2 (Reuters) - Abbisko Cayman Ltd 2256.HK:
ABBISKO THERAPEUTICS AND ASTRAZENECA ENTER A STRATEGIC COLLABORATION
CO AND ASTRAZENECA ENTER STRATEGIC COLLABORATION FOR LUMIPODLIN CLINICAL TRIAL IN NSCLC
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains